Application of circulating tumor DNA in breast cancer

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Precision medicine has been well recognized since it was proposed, and the invention of liquid biopsy meets the needs of this era. Circulating tumor DNA (ctDNA), one of the most promising components of liquid biopsies, has quickly become the focus of research in recent years because of its unique advantages in clinical application. This article reviews the clinical application of ctDNA in breast cancer detection in recent years and its potential clinical value.
Funding Information
  • National Natural Science Foundation of China-Yunnan Joint Fund (81760262)

This publication has 22 references indexed in Scilit: